Rhythm Biosciences Ltd has released a press release.
Rhythm Receives $2.4m R&D Tax Incentive
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Rhythm Completes Recruitment for Clinical Trial (Study 7)
- TGA Accepts Initial Regulatory Documentation
- Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
- Initial TGA Regulatory Documentation Submitted
- Non Renounceable pro rata offer - Completion of despatch
Later from Rhythm Biosciences
- ColoSTAT Test Kits Deliver Consistent, High Accuracy Results
- RHY - Institutional Investor Presentation
- Application for quotation of securities - RHY
- Change of Director's Interest Notice x 4
- CE Mark Granted for ColoSTAT
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences